Loading...

Inogen, Inc.

INGNNASDAQ
HealthcareMedical - Devices
$5.88
$-0.26(-4.23%)

Inogen, Inc. (INGN) Stock Overview

Explore Inogen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
6.35%
6.35%
Profit Growth
$-1.09
64.97%
EPS Growth
$-1.09
65.61%
Operating Margin
-9.67%
61.13%
ROE
-14.76%
64.97%
Dividend Yield
0.00%
Analyst Recommendations data is not available for INGNAnalyst Recommendations details for INGN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

CEO

Mr. Kevin R. M. Smith

Employees

766

Headquarters

301 Coromar Drive, Goleta, CA

Founded

2014

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.